Cancer clinical trials in the region Nouvelle-Aquitaine
239 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 1 / Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Endometrial cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Lung cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Colon cancer
Rectal cancer
#NCT04626635
#2022-501234-37-00
Metastatic
MSS/pMMR
1
2
3 or more
Systemic Treatment-Naive
Immunotherapy
Institut Bergonié (Bordeaux), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers)
Regeneron Pharmaceuticals
Phase 1 / Phase 2
Prostate cancer
#NCT04104776
#2023-508002-20-00
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M6
Metastatic Castration-resistant
1
2
3 or more
Chemotherapy
Hormone therapy
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
Constellation Pharmaceutique
Phase 1 / Phase 2
Breast cancer
Lung cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
#NCT04104776
#2023-508002-20-00
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M1
Urothelial carcinoma
Locally Advanced
Metastatic
ARID1A
1
2
3 or more
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
Constellation Pharmaceutique
Phase 1 / Phase 2
Endometrial cancer
#NCT04104776
#2023-508002-20-00
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M7
Endometrioid adenocarcinoma
Serous adenocarcinoma
Clear cell carcinoma
Dedifferentiated and undifferentiated endometrial ...
Locally Advanced
Metastatic
1
2
Immunotherapy
Chemotherapy
ARID1A
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
Constellation Pharmaceutique
Phase 1 / Phase 2
Prostate cancer
#NCT04104776
#2023-508002-20-00
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M8
Metastatic Hormone-sensitive
Metastatic Castration-resistant
1
2
3 or more
Chemotherapy
Hormone therapy
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
Constellation Pharmaceutique
Phase 1 / Phase 2
Lung cancer
#NCT04104776
#2023-508002-20-00
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M5
Mesothelium
Locally Advanced
Metastatic
Other mutation
1
2
3 or more
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
Constellation Pharmaceutique